|Bid||1.4000 x 1200|
|Ask||1.4300 x 800|
|Day's Range||1.3300 - 1.4800|
|52 Week Range||1.2000 - 13.1200|
|Beta (3Y Monthly)||2.44|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. iBio (NYSE: IBIO ) shares were down 14% to ...
The bullish start to the week fizzled out on Tuesday, despite mostly-optimistic chatter. Credit Suisse's "recession dashboard" says there's not one in sight. "Key signals such as labor and credit trends remain quite healthy," explains Credit Suisse chief U.S. equity strategist Jonathan Golub.And, while he laments it, fund manager Kyle Bass made the case that central banks are going to continue doing anything and everything they can to keep the global economy propped up. JPMorgan's global head of quantitative and derivatives strategy Marko Kolanovic even went as far as saying last week's temporary inversion of the yield curve wasn't the cause for worry it might normally be.InvestorPlace - Stock Market News, Stock Advice & Trading TipsDisruption in Europe may have been the crux of the weakness. The United Kingdom may postpone the selection of the Bank of England's next governor until after Brexit, though Brexit itself remains up in the air. In Italy, Prime Minister Giuseppe Conte announced his resignation, simultaneously criticizing Deputy Prime Minister Matteo Salvini for calling for the no-confidence vote that led to his exit.Both cast a cloud of uncertainty over Europe, which was already struggling to maintain economic growth. * 10 Undervalued Stocks With Breakout Potential All told, the S&P 500 snapped a three-day win streak with its 0.53% setback on Tuesday. The Dow Jones Industrial Average wasn't quite as damaged, falling 0.37%, while the NASDAQ Composite ended the day 0.45% lower. Top News in the Stock Market TodayIt had little impact on shares, but it's a developing story that could matter more in the future. That is, on Tuesday, a string of personnel exits from the healthcare arm being developed by Apple (NASDAQ:AAPL) was thrust into the spotlight. The report named six key people who'd left the company in recent months, reportedly frustrated about the direction Apple's health business was moving. Some employees interviewed anonymously suggested tensions had been mounting for some time. The disruption calls into question how much traction Apple's health initiatives will garner in the foreseeable future.Walt Disney Company (NYSE:DIS) joined General Electric (NYSE:GE) as a recent accusee of misleading accounting, though in this case, the red flag is being waved by a former insider. Sandra Kuba, formerly a senior financial analyst with Disney that was terminated in 2017, suggested the entertainment giant had habitually reported more revenue than it had actually generated. Kuba went as far as to formally inform the Securities and Exchange Commission.Walt Disney denied the accusation, and given the small gain DIS stock mustered on an otherwise bearish day, investors aren't concerned.Investors are concerned about Sarepta Therapeutics (NASDAQ:SRPT), however, after the Food and Drug Administration responded to its most recent drug approval request with less than open arms. The FDA sent a so-called Complete Response Letter to Sarepta regarding concerns and questions it had about its Duchenne muscular dystrophy drug that's been in development for years.The letter is not a rejection, but it does suggest the FDA is so far unconvinced that the drug is worth greenlighting. SRPT stock fell more than 15% on the news. Big MoversDespite its clear capacity to put and keep itself in the spotlight, "meatless" meat company Beyond Meat (NASDAQ:BYND) hasn't impressed the analyst community. Until Tuesday, no analyst was willing to call the stock a "Buy" … that is, until today. JPMorgan analyst Ken Goldman upgraded BYND stock to that rating, explaining "We are encouraged that velocity -- sales per distribution point -- has been the primary driver of recent acceleration, as it suggests the products are catching on with consumers."The call pushed Beyond Meat shares up by more than 6%.It's not much of a household name, but for households that own a piece of electronics manufacturer Cemtrex (NASDAQ:CETX), that stake is worth 36% more today. Shares jumped nearly 30% in regular-hours action on Tuesday following an impressive second quarter report that saw an additional 6% advance in after-hours action. The promise of real profits within the next few quarters fanned the bullish flames.Not every big mover was necessarily a winner though. Madison Square Garden (NYSE:MSG) tumbled nearly 9% after the company's second-quarter bottom line fell short of estimates. Its new project in Las Vegas is proving costly but not fruitful.As of the time of this writing, James Brumley did not hold a position in any of the aforementioned securities. To learn more about James, visit his site at jamesbrumley.com, or follow him on twitter at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Cheap Dividend Stocks to Load Up On * The 10 Biggest Losers from Q2 Earnings * 5 Dependable Dividend Stocks to Buy The post Stock Market Today: Beyond Meat Makes a Friend on Wall Street appeared first on InvestorPlace.
Shares of Cemtrex Inc. shot up 71% on heavy volume to pace all Nasdaq gainers Tuesday, after the provider of manufacturing services and engineered electronics reported a narrower second-quarter loss, a rise in revenue and said it expects improvement to profitability over the next few quarters. Trading volume jumped to over 10.6 million shares, compared with the full-day average of about 342,000 shares. The net loss narrowed to $3.1 million, or $1.59 a share, from $4.1 million, or $2.41 a share, in the same period a year ago, while total revenue grew to $22.45 million from $19.16 billion. The company said expenses increased during the quarter because of one-time finance and legal charges. "We have implemented a number of changes in our organization to focus on increasing cash flow from operations which have already started to materialize," said Chief Executive Saagar Govil. The stock has still tumbled 44% year to date, while the Nasdaq Composite has climbed 20% and the S&P 500 has gained 16%.
The big shareholder groups in Cemtrex, Inc. (NASDAQ:CETX) have power over the company. Insiders often own a large...
A shift in consumer behavior has pushed a number of luxury brands to improve their online presence and adopt new technology, with companies eager to profit from e-commerce sales. By 2022, e-commerce will ...
Cemtrex (NASDAQ: CETX ) has developed an immersive augmented reality experience for seven luxury brands housed under Richemont, Arcadium. Arcadium’s augmented reality experience is custom engineered and ...
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Cemtrex, Inc. (NASDAQ: CETX ) shares were ...
Fuel Tech's (FTEK) APC segment will benefit from solid pipeline of contract opportunities for its technology suite, business relationships with industrial end-users & greater operational efficacy.
Cemtrex Inc. (CETX) delivered earnings and revenue surprises of -9.09% and -18.27%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Let's face it, big tech companies haven't been very innovative. Earlier this month, Apple Inc. warned about slowing sales. Samsung shares a similar sentiment. Recently the company projected a sharp sales and profit decline.
If you want to know who really controls Cemtrex, Inc. (NASDAQ:CETX), then you'll have to look at the makeup of its share registry. Institutions often own shares in more established Read More...
Saagar Govil became the CEO of Cemtrex Inc (NASDAQ:CETX) in 2011. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will consider the Read More...